Clinical trial
A Study of Granulocyte Colony-Stimulating Factor Plus Recombinant Erythropoietin…
NCT00002281 · Amgen, Industry · Completed
Key facts
| NCT number | NCT00002281 |
|---|---|
| Title | A Study of Granulocyte Colony-Stimulating Factor Plus Recombinant Erythropoietin Plus Zidovudine in Patients With AIDS or AIDS-Related Complex |
| Official title | An Open Label Phase I/II Study of Recombinant Granulocyte Colony-Stimulating Factor (r-metHuG-CSF) and Recombinant Erythropoietin (rHuEPO) Given Subcutaneously Along With Zidovudine (AZT) to Patients With AIDS or ARC |
| Lead sponsor | Amgen, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | HIV Infections, Cytopenias |
| Intervention type | Drug |
| Interventions | Filgrastim, Epoetin alfa, Zidovudine |
| Enrollment | 24 |
| First posted | Aug 31, 2001 |
| Last update posted | Jun 24, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: